TY - JOUR AU -  Muhammad Tahir , Bilqees Fatima , Arfa Nawazish , Iram Kehkashan Khurshid , Sana Gul ,  Muhammad Tahir , Bilqees Fatima , Arfa Nawazish , Iram Kehkashan Khurshid , Sana Gul PY - 2019/09/18 Y2 - 2024/03/28 TI - CDX-2 expression in colorectal cancer: A single centre study from Pakistan JF - Journal of Rawalpindi Medical College JA - JRMC VL - 23 IS - 3 SE - Articles DO - UR - http://journalrmc.com/index.php/JRMC/article/view/1206 SP - AB - <p><strong>Introduction:</strong><strong>&nbsp; </strong>Tumors of the gastrointestinal (GI) tract, share a major burden for mortality and morbidity all over the world. The most common site of carcinoma of GIT is colon and rectum (70%). The etiological factors may be environmental (diet) and genetic. CDX-2 has been proposed as being present in most of the cases with colorectal carcinoma.</p><p><strong>Objective</strong><strong>: </strong>To determine the frequency of positive expression of CDX2 in diagnosed cases of colorectal adenocarcinoma diagnosed on haematoxylin and eosin stain.</p><p><strong>Material and Methods:</strong></p><p>This was a cross-sectional study and was conducted at ---(deleted for blind review)--- over period of 2 years We included all paraffin embedded tissue sections of colorectal carcinoma of both genders with an age range of 25-75 years. Specimens were stained with Heamatoxylin and Eosin (H &amp; E) and examined microscopically for presence or absence of invasive cancer. Another specimen was taken and stained with CDX2. The data were analyzed using SPSS version 24.</p><p><strong>Results</strong><strong>: </strong>A total of 125 cases with colorectal carcinoma diagnosed on H &amp; E stain were included in the study. The mean age of the patients was found to be 52.66 ± 14.62 years. In this study, 67 patients (53.6%) were male and 58 patients (46.4%) were having final diagnosis of Adenocarcinoma. Regarding the site, most common lesion involved rectum, followed by sigmoid colon and ascending colon. Among 125 specimens reviewed, 112 patients (89.6%) were CDX-2 positive while 13 patients (10.4%) were CDX-2 negative. Also we stratified the CDX-2 expression according to site and type of colorectal carcinoma and was found significant for both of these (P&lt;0.05).</p><p><strong>Conclusion</strong>: We concluded that CDX-2 was present in almost 90% of colorectal carcinoma specimens so it can be used as an important diagnostic tool for colorectal carcinoma during histopathological diagnosis.</p><p><strong>Keywords</strong><strong>: </strong>Colorectal carcinoma; CDX-2; Hematoxylin; Eosin</p> ER -